Herbal Approaches to Pediatric Functional Abdominal Pain

Rebecca N Cherry1, Samra S Blanchard2, Ashish Chogle3

  • 1Deep Well Health Care, Elkins Park, PA 19027, USA.

Insights

Herbal remedies like peppermint oil and Iberogast show promise for treating pediatric functional abdominal pain disorders. While research is limited, these treatments are generally safe and effective, warranting further investigation.

Area of Science:

  • Pediatric Gastroenterology
  • Complementary and Integrative Medicine
  • Functional Gastrointestinal Disorders

Background:

  • Chronic abdominal pain affects about 20% of children globally, often diagnosed as abdominal-pain-related functional gastrointestinal disorders (AP-FGIDs) per Rome IV criteria.
  • AP-FGIDs encompass conditions like functional dyspepsia, irritable bowel syndrome (IBS), functional abdominal pain, and abdominal migraine, with IBS being the most common.
  • The development of AP-FGIDs is multifactorial, involving genetics, early life experiences, psychosocial factors, and altered physiological processes such as visceral sensitivity and central nervous system processing.

Purpose of the Study:

  • To review popular herbal treatments used in complementary medicine for pediatric AP-FGIDs.
  • To assess the efficacy and safety of these herbal remedies based on available scientific data.

Main Methods:

  • Literature review of herbal treatments for pediatric AP-FGIDs.
  • Analysis of studies on peppermint oil, Iberogast, cannabis, fennel, and licorice.

Main Results:

  • Available studies suggest these herbal remedies are generally well-tolerated with minimal side effects.
  • Evidence indicates these treatments are at least as effective as placebo for pediatric AP-FGIDs.
  • High-quality data supporting efficacy is limited, necessitating further research.

Conclusions:

  • Herbal treatments are of significant interest for pediatric AP-FGIDs.
  • While promising, more rigorous placebo-controlled studies are required to confirm efficacy and safety.
  • These complementary approaches may offer valuable options alongside conventional treatments for children with chronic abdominal pain.

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
278
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
277
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
304
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
302
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
305
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
138